S66 ASX Chart
Snapshot
Star Combo Pharma Ltd (S66) is a contract manufacturer of vitamins, health and beauty products with a portfolio of own brands and distribution capabilities. Products are made from natural ingredients with scientific R&D and adheres to manufacturing practices governed by the Therapeutic Goods Administration. Star Combo currently supplies the Australian pharmacy network through 450 Terry White Chemmart stores as well as wholesale customers in Australia, Vietnam and China.
Share Price Activity (ASX)
Last (Price) | |
Change | 0.00 (0.00) |
Bid / Ask | - |
Volume | |
Volume (4w avg) | |
Turnover | |
Open | |
Day Range | - |
VWAP | |
Prev Close | |
Last Trade |
Performance
1 Week | |
1 Month | |
2024 YTD | |
1 Year | |
vs Sector (1yr) | +50.68% |
vs ASX 200 (1yr) | +40.89% |
Announcements
Corporate Overview
Corporate Details
Head Office | Smithfield NSW 2164 |
Website | www.starcombo.com.au |
Registry | Link Market Services |
Auditor | GCC Business & Assurance Pty Ltd |
Date Listed | 16 May 2018 |
Upcoming Calendar (Forecasted)
Date | Event |
---|---|
14/10/2024 | Div Ex Date |
15/10/2024 | Books Close |
25/10/2024 | Report (Annual) |
31/10/2024 | Div Pay Date |
Former Company Names
- Star Combo Pharma Ltd has no former company names.
Sponsored Financial Content
Dividend History
DPS and Yield calculations use the Pay Date.
See Upcoming Dividends for all ASX companies.
Key Data | |
---|---|
DPS(TTM) | $0.00 |
Gross DPS(TTM) | $0.00 |
Dividend yield |
|
Gross yield |
|
Payout Ratio | 67% |
DRP | No |
DRP Features | - |
Directors & Management
Directors
Management
Director Interests
The current holdings of S66 directors.
Shareholder Info
Substantial Shareholders
A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.
Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.
Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.
Name | Last Notice | Total Shares | Shares Held (%) |
---|---|---|---|
Su Zhang | 17/10/2023 | 11,448,980 | 8.48 |
Jinxing Star Zhang | 17/10/2023 | 38,165,510 | 28.25 |
Lepu Medical Europe Cooperatief UA | 17/10/2023 | 11,000,000 | 8.14 |
Goldenstar Pharmaceutical Investment Limited | 17/10/2023 | 49,000,000 | 36.27 |
Shareholders Buying
12 month transaction history compiled from ASX announcements.
No buy transactions reported by Substantial Shareholders in the past 12 months.
Shareholders Selling
12 month transaction history compiled from ASX announcements.
No sell transactions reported by Substantial Shareholders in the past 12 months.
Historical Data
Share Price History
Date | Close | Change | %Chg | Open | High | Low | Volume | Turnover |
---|---|---|---|---|---|---|---|---|
Historical Data
Year | Closing Price | Last Trade |
---|---|---|
2024 | $0.11 | 28 June |
2023 | $0.11 | 30 June |
2022 | $0.155 | 30 June |
2021 | $0.255 | 30 June |
2020 | $0.40 | 30 June |
2019 | $0.695 | 28 June |
2018 | $0.87 | 29 June |
Important note:
All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.